A detailed history of Quest Partners LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 9,004 shares of ATXS stock, worth $106,427. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,004
Previous 3,206 180.85%
Holding current value
$106,427
Previous $29.2 Million 239.79%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$8.97 - $12.65 $52,008 - $73,344
5,798 Added 180.85%
9,004 $99.1 Million
Q2 2024

Aug 06, 2024

BUY
$8.83 - $13.51 $27,478 - $42,043
3,112 Added 3310.64%
3,206 $29.2 Million
Q1 2024

May 09, 2024

BUY
$6.99 - $16.69 $657 - $1,568
94 New
94 $1.32 Million

Others Institutions Holding ATXS

About Astria Therapeutics, Inc.


  • Ticker ATXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,178,000
  • Market Cap $179M
  • Description
  • Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...
More about ATXS
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.